133 related articles for article (PubMed ID: 31151970)
1. Paraneoplastic erythroderma: unusual presentation secondary to diffuse large B cell lymphoma.
Lim PN; Fox CP; Pammi M; Patel A
BMJ Case Rep; 2019 May; 12(5):. PubMed ID: 31151970
[TBL] [Abstract][Full Text] [Related]
2. Paraneoplastic erythroderma: an unusual manifestation of diffuse large B-cell lymphoma.
Yang JH; Choi SJ; Won CH; Chang S; Lee MW; Huh JR; Lee KH; Choi JH; Moon KC
Int J Dermatol; 2013 Sep; 52(9):1149-51. PubMed ID: 23962267
[No Abstract] [Full Text] [Related]
3. Paraneoplastic erythroderma in a prostate cancer patient.
Momm F; Pflieger D; Lutterbach J
Strahlenther Onkol; 2002 Jul; 178(7):393-5. PubMed ID: 12163994
[TBL] [Abstract][Full Text] [Related]
4. Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles.
Cunningham D; Hawkes EA; Jack A; Qian W; Smith P; Mouncey P; Pocock C; Ardeshna KM; Radford JA; McMillan A; Davies J; Turner D; Kruger A; Johnson P; Gambell J; Linch D
Lancet; 2013 May; 381(9880):1817-26. PubMed ID: 23615461
[TBL] [Abstract][Full Text] [Related]
5. Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b study.
Younes A; Thieblemont C; Morschhauser F; Flinn I; Friedberg JW; Amorim S; Hivert B; Westin J; Vermeulen J; Bandyopadhyay N; de Vries R; Balasubramanian S; Hellemans P; Smit JW; Fourneau N; Oki Y
Lancet Oncol; 2014 Aug; 15(9):1019-26. PubMed ID: 25042202
[TBL] [Abstract][Full Text] [Related]
6. Renal cell carcinoma presenting as exfoliative dermatitis (erythroderma) - a case report.
Yan K; Liu C; Xu Z; Liu Z; Wang K; Jiang Y; Fan Y
Clin Nephrol; 2013 Jul; 80(1):63-6. PubMed ID: 22575379
[TBL] [Abstract][Full Text] [Related]
7. Cardiotoxicity with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine and prednisolone compared to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone in frontline treatment of patients with diffuse large B-cell lymphoma: A randomised phase-III study from the Austrian Cancer Drug Therapy Working Group [Arbeitsgemeinschaft Medikamentöse Tumortherapie AGMT](NHL-14).
Fridrik MA; Jaeger U; Petzer A; Willenbacher W; Keil F; Lang A; Andel J; Burgstaller S; Krieger O; Oberaigner W; Sihorsch K; Greil R
Eur J Cancer; 2016 May; 58():112-21. PubMed ID: 26990931
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of sarcopenia in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.
Go SI; Park MJ; Song HN; Kim HG; Kang MH; Lee HR; Kim Y; Kim RB; Lee SI; Lee GW
J Cachexia Sarcopenia Muscle; 2016 Dec; 7(5):567-576. PubMed ID: 27104110
[TBL] [Abstract][Full Text] [Related]
9. [An unusual paraneoplastic manifestation in lung cancer: eosinophilic erythroderma].
Andriamanantena D; Boye T; Gervaise A; Vieu C; Splingard B; Dot JM; Veran Y; Margery J
Rev Pneumol Clin; 2009 Feb; 65(1):32-5. PubMed ID: 19306782
[TBL] [Abstract][Full Text] [Related]
10. Diffuse large B-cell lymphoma of stomach presenting with paraneoplastic cerebellar degeneration syndrome.
Nomani AZ; Wazir M; Kashmir SB; Qureshi MS
J Coll Physicians Surg Pak; 2014 Mar; 24 Suppl 1():S11-3. PubMed ID: 24717988
[TBL] [Abstract][Full Text] [Related]
11. Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial.
Récher C; Coiffier B; Haioun C; Molina TJ; Fermé C; Casasnovas O; Thiéblemont C; Bosly A; Laurent G; Morschhauser F; Ghesquières H; Jardin F; Bologna S; Fruchart C; Corront B; Gabarre J; Bonnet C; Janvier M; Canioni D; Jais JP; Salles G; Tilly H;
Lancet; 2011 Nov; 378(9806):1858-67. PubMed ID: 22118442
[TBL] [Abstract][Full Text] [Related]
12. Exfoliative dermatitis. Erythroderma can be a sign of a significant underlying disorder.
Jaffer AN; Brodell RT
Postgrad Med; 2005 Jan; 117(1):49-51. PubMed ID: 15672891
[TBL] [Abstract][Full Text] [Related]
13. A Rare Case of Diffuse Large B Cell Lymphoma Presenting as a Cardiac Mass.
Yousif P; Kotecha A; Thakur A; Ismail HM
Am J Case Rep; 2019 Dec; 20():1821-1825. PubMed ID: 31809493
[TBL] [Abstract][Full Text] [Related]
14. Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised phase 3 trial.
Delarue R; Tilly H; Mounier N; Petrella T; Salles G; Thieblemont C; Bologna S; Ghesquières H; Hacini M; Fruchart C; Ysebaert L; Fermé C; Casasnovas O; Van Hoof A; Thyss A; Delmer A; Fitoussi O; Molina TJ; Haioun C; Bosly A
Lancet Oncol; 2013 May; 14(6):525-33. PubMed ID: 23578722
[TBL] [Abstract][Full Text] [Related]
15. The coexistence of renal cell carcinoma and diffuse large B-cell lymphoma with hypercalcemic crisis as the initial presentation.
Yilmaz H; Namuslu M; Bilgic MA; Bavbek N; Akcay A
Endocr Regul; 2014 Jul; 48(3):113-9. PubMed ID: 25110209
[TBL] [Abstract][Full Text] [Related]
16. Diffuse Large B Cell Lymphoma in a Male Breast - A Rare Case Report.
Corobea AB; Dumitru A; Sajin M; Poenaru R; Puşcaşu A; Chirita D; Evsei A
Chirurgia (Bucur); 2017; 112(4):477-481. PubMed ID: 28862126
[TBL] [Abstract][Full Text] [Related]
17. Erythroderma as a paraneoplastic cutaneous disorder in systemic anaplastic large cell lymphoma.
Hanafusa T; Igawa K; Takagawa S; Yahara H; Harada J; Tani M; Sawada Y; Katayama I
J Eur Acad Dermatol Venereol; 2012 Jun; 26(6):710-3. PubMed ID: 21707767
[TBL] [Abstract][Full Text] [Related]
18. Gastric diffuse large B cell lymphoma presenting as paraneoplastic cerebellar degeneration: case report and review of literature.
Lakshmaiah KC; Viveka BK; Anil Kumar N; Saini ML; Sinha S; Saini KS
J Egypt Natl Canc Inst; 2013 Dec; 25(4):231-5. PubMed ID: 24207096
[TBL] [Abstract][Full Text] [Related]
19. Erythroderma and exfoliative dermatitis.
Wilson DC; Jester JD; King LE
Clin Dermatol; 1993; 11(1):67-72. PubMed ID: 8339203
[No Abstract] [Full Text] [Related]
20. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Coiffier B; Lepage E; Briere J; Herbrecht R; Tilly H; Bouabdallah R; Morel P; Van Den Neste E; Salles G; Gaulard P; Reyes F; Lederlin P; Gisselbrecht C
N Engl J Med; 2002 Jan; 346(4):235-42. PubMed ID: 11807147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
